Neurocrine Clinical Site

Oceanside, California 92056

4 studies enrolling now · 8 studies all time

What they study most

Major Depressive Disorder, Schizophrenia, Tardive Dyskinesia, Tardive Dyskinesia (TD)

Studies at this site

• Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) — Recruiting now
• A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) — Recruiting now
• Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia — Recruiting now
• NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia — Recruiting now
• Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia — Completed
• Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia — Stopped early
• The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine — Completed
• Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents — Status unconfirmed